Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20052
20081
20091
20102
20112
20123
20134
20146
20158
20164
20173
20184
20196
20208
20215
202211
20239
20249
202525
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting34
Unknown status11
Not yet recruiting11
Terminated11
Active, not recruiting7
Withdrawn5
Enrolling by invitation3
No longer available2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx9
University of Aarhus6
CSL Behring5
Takeda5
Tongji Hospital5
Sanofi4
Centre Hospitalier Universitaire de Nice3
Heinrich-Heine University, Duesseldorf3
Immunovant Sciences GmbH3
Istituto Clinico Humanitas3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating136
Myasthenia Gravis14
Guillain-Barre Syndrome12
Autoimmune Diseases of the Nervous System11
Multiple Sclerosis11
Neuromyelitis Optica11
Autoimmune Diseases9
Charcot-Marie-Tooth Disease9
Peripheral Nervous System Diseases9
Myositis6

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.